Sector: Life Sciences

Latest content

Dutch courts will still award cross-border injunctions to patent holders despite Boston Scientific setback

The refusal of a judge in Amsterdam to grant the US company relief covering Ireland, France and Germany does not indicate major change to the regime

28 June 2022

Data monetisation gathers momentum in the healthcare sector

Life sciences innovators are increasingly paying for access to high-quality data

27 June 2022

Pfizer in crosshairs once again in latest covid-19-related patent suit

Enanta Pharmaceuticals is seeking a share of blockbuster antiviral revenues

24 June 2022

French appeal court SPC decision is good news for biologics innovators

Following a string of adverse rulings against inventors, Paris Court of Appeal overturns patent office rejection of supplementary protection certificate on Article 3(a) grounds

20 June 2022

Covid impact on US patent filings is now becoming clearer

Data on law firms ranked by 2021 grants shows a slide that may link to filing strategies changing because of pandemic-induced budget cuts

17 June 2022

Breaking: Vaccine IP waiver agreed by WTO members

The agreed IP waiver is less far-reaching than the original proposal, but underscores how the pandemic has impacted IP politics.

17 June 2022

Five IP strategy lessons from the Herceptin patent wars

Dispute's over Genentech's trastuzumab have helped write the patent playbook for innovators and imitators in the biologics space

07 June 2022

GSK’s $3.3 billion buyout shows vaccine IP boom goes beyond mRNA

Affinivax acquisition based on platform tech licensed from Boston Children’s Hospital

06 June 2022

UCal further strengthens CRISPR position in Europe, but Cas9 licensing situation remains tricky

EPO Opposition Division upholds another key Doudna patent, but several gene-editing appeals are still in play

26 May 2022

EPO chief economist: IP practitioners should use commercial nous to help Europe’s Deep Tech sector

IAM speaks to Yann Ménière of the European Patent Office about how the patent profession can best support Fourth Industrial Revolution innovators

23 May 2022

Unlock unlimited access to all IAM content